Page last updated: 2024-08-21

2-tert-butylhydroquinone and Hepatoblastoma

2-tert-butylhydroquinone has been researched along with Hepatoblastoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jaiswal, AK; Niture, SK1

Other Studies

1 other study(ies) available for 2-tert-butylhydroquinone and Hepatoblastoma

ArticleYear
Nrf2-induced antiapoptotic Bcl-xL protein enhances cell survival and drug resistance.
    Free radical biology & medicine, 2013, Volume: 57

    Topics: Animals; Antineoplastic Agents, Phytogenic; Antioxidant Response Elements; Antioxidants; Apoptosis; bcl-X Protein; Carcinoma, Hepatocellular; Caspases; Cell Line, Tumor; Cell Survival; Cytoprotection; Drug Resistance, Neoplasm; Etoposide; HEK293 Cells; Hepatoblastoma; Humans; Hydroquinones; Intracellular Signaling Peptides and Proteins; Kelch-Like ECH-Associated Protein 1; Liver Neoplasms; Mice; NF-E2-Related Factor 2; Promoter Regions, Genetic; RNA Interference

2013